Skip to content
HowShorted

Inhibikase Therapeutics, Inc. short interest in 2021

In 2021, Inhibikase Therapeutics, Inc.'s disclosed short interest ran from 0.63% of shares outstanding on 30 Apr 2021 to 0.67% on 31 Dec 2021, a change of +0.04 percentage points. The year's high was 1.50% on 15 Nov 2021 and its low 0.35% on 15 Sep 2021, averaging 0.71% across 11 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 3.90 days on 14 May 2021. Full history: Inhibikase Therapeutics, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for Inhibikase Therapeutics, Inc. in 2021

2021 in figures

Start of year
0.63% (30 Apr 2021)
End of year
0.67% (31 Dec 2021)
Change
+0.04 pp
High
1.50% (15 Nov 2021)
Low
0.35% (15 Sep 2021)
Average
0.71%
Highest days to cover
3.90 (14 May 2021)
SEC filings marked
5

Every report in 2021

Inhibikase Therapeutics, Inc. short interest in 2021
SettlementShort interestDays to coverFilings since previous
30 Apr 20210.63%3.1510-K filed, results (8-K)
14 May 20210.64%3.90
28 May 20210.62%2.6910-Q filed
15 Jun 20210.59%1.00
13 Aug 20210.67%1.00
31 Aug 20210.40%1.0010-Q filed
15 Sep 20210.35%1.00
15 Nov 20211.50%2.6510-Q filed
30 Nov 20210.87%1.00
15 Dec 20210.90%1.00
31 Dec 20210.67%1.00

See also: Inhibikase Therapeutics, Inc.'s full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.